Leuprolide and blood alkaline phosphatase increased 
Leuprolide and blood alkaline phosphatase increased Patient Reports February 12, 2012
Leuprolide Side Effects Report #5794223-7
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 17, 2008. Male patient, 77 years of age, was diagnosed with prostate cancer stage iv, hypertension, hyperlipidaemia, atrial fibrillation
, hyperuricaemia, stomach discomfort, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebellar haemorrhage, hepatic function abnormal, red blood cell count decreased. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, NISOLDIPINE, PRAVASTATIN, WARFARIN, ALLOPURINOL, P MAGEN, HARNAL D. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5814243-3
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on July 17, 2008. Male patient, 77 years of age, was diagnosed with prostate cancer stage iv, hypertension, hyperlipidaemia, atrial fibrillation
, hyperuricaemia, stomach discomfort, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebellar haemorrhage, hepatic function abnormal, red blood cell count decreased. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, NISOLDIPINE, PRAVASTATIN, WARFARIN POTASSIUM, ALLOPURINOL, P MAGEN, HARNAL D. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5816898-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on July 17, 2008. Male patient, 77 years of age, was diagnosed with prostate cancer stage iv, hypertension, hyperlipidaemia, atrial fibrillation
, hyperuricaemia, stomach discomfort, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, cerebellar haemorrhage, hepatic function abnormal, red blood cell count decreased. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, NISOLDIPINE, PRAVASTATIN, WARFARIN POTASSIUM, ALLOPURINOL, P MAGEN, HARNAL D. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #5938303-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Oct 23, 2008. Male patient, 76 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, cerebral infarction. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, BICALUTAMIDE, ESTRAMUSTINE PHOSPHATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #5977656-5
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 19, 2008. Male patient, 76 years of age, was diagnosed with prostate cancer stage iv and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, cerebral infarction, hemiplegia. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, BICALUTAMIDE, ESTRAMUSTINE PHOSPHATE, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #5332500-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on May 17, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: adenocarcinoma, aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiac tamponade, cardiomegaly, hepatic function abnormal, lung neoplasm malignant, lymphadenopathy mediastinal, malaise. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with FLUTAMIDE, PLETAAL, JUVELA N, PROCYLIN, DEPAKENE. Patient recovered.
Leuprolide Side Effects Report #5353027-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on June 04, 2007. Male patient, 77 years of age, was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiac tamponade, lung adenocarcinoma, lung neoplasm malignant, lymphadenopathy mediastinal, neck pain, oedema peripheral, pericardial effusion. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK) SUBCUTANEOUS. During the same period patient was treated with FLUTAMIDE, PLETAAL, JUVELA N, PROCYLIN, DEPAKENE. Patient recovered.
Leuprolide Side Effects Report #5247989-9
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Feb 19, 2007. Female patient was diagnosed with prostate cancer stage iii and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, cardiac tamponade, cardiomegaly, hepatic function abnormal, lung neoplasm malignant, lymphadenopathy mediastinal, malaise, neck pain. Leuprolide dosage: 11.25 MG, SUBCUTANEOUS, 1 IN 12 WEEKS. During the same period patient was treated with FLUTAMIDE, PLETAAL, JUVELA N, PROCYLIN, DEPAKENE. Patient recovered.
Leuprolide Side Effects Report #5915044-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Oct 01, 2008. Male patient, 78 years of age, was diagnosed with prostate cancer stage ii, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, gastric ulcer haemorrhage, haemoglobin decreased. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, AVISHOT. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #6016936-4
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Dec 17, 2008. Male patient, 78 years of age, was diagnosed with prostate cancer stage ii, benign prostatic hyperplasia and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, gastric ulcer haemorrhage, haemoglobin decreased. Leuprolide dosage: unknown. During the same period patient was treated with LEUPROLIDE ACETATE, AVISHOT, ZALTOPROFEN. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #5870162-8
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 25, 2008. Male patient, 69 years of age, weighting 138.9 lb, was diagnosed with prostate cancer stage ii, neuropathy peripheral, gastric ulcer, hypertension and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: bile duct stone, blood alkaline phosphatase increased, blood cholesterol increased, pancreatitis acute. Leuprolide dosage: unknown. During the same period patient was treated with BICALUTAMIDE, MECOBALAMIN, CASTER D, ATENOLOL. Patient was hospitalized. Patient recovered.
Leuprolide Side Effects Report #4686065-0
Leuprolide side effect was reported by a Consumer or non-health professional from on May 31, 2005. Male patient, 92 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, condition aggravated, cyanosis. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D). Patient recovered.Leuprolide Side Effects Report #4745007-X
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Aug 09, 2005. Male patient, 92 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatine phosphokinase increased, blood culture positive, blood lactate dehydrogenase increased, blood urea increased, condition aggravated, hepatic function abnormal. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. Patient recovered.Leuprolide Side Effects Report #5277979-1
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Mar 13, 2007. Male patient, 86 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, brain stem infarction, cerebral circulatory failure, cerebral infarction, eye disorder, eyelid function disorder. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 28 D) SUBCUTANEOUS. During the same period patient was treated with HARNAL D, BLADDERON, TRYPTANOL. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4820872-6
Leuprolide side effect was reported by a Consumer or non-health professional from JAPAN on Nov 01, 2005. Male patient, 78 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, antinuclear antibody positive, aspartate aminotransferase increased, b-lymphocyte count increased, blood alkaline phosphatase increased, cardiac disorder, cardiac failure congestive, chromosome banding, condition aggravated. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, NITRODERM, PROSTATE. Patient was hospitalized and became disabled. Patient recovered.Leuprolide Side Effects Report #4772935-1
Leuprolide side effect was reported by a Consumer or non-health professional from GERMANY on Sept 14, 2005. Male patient, 65 years of age, was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, asthenia, blood alkaline phosphatase increased, blood immunoglobulin a increased, fatigue, gamma-glutamyltransferase increased, hepatic cirrhosis, hepatic steatosis. Leuprolide dosage: 3.75 MG (3.75 MG, 1 IN 1 M) SUBCUTANEOUS. During the same period patient was treated with DEXAMETHASONE, CORDAREX, DIGIMERCK MINOR, ACETYLSALICYLIC ACID, CODEINE SUL, BERODUAL, SYMBICORT, PANTOZOL. Patient recovered.Leuprolide Side Effects Report #4644741-X
Leuprolide side effect was reported by a Consumer or non-health professional from on Apr 20, 2005. Male patient was diagnosed with prostate cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, jaundice , lymphocyte stimulation test positive. Leuprolide dosage: 11.25 MG (11.25 MG, 1 IN 12 WK). During the same period patient was treated with LEUPROLIDE ACETATE, WARFARIN, DIGOXIN, FLIVAS, CHLORMADINONE ACETATE. Patient was hospitalized. Patient recovered.Leuprolide Side Effects Report #4952075-9
Leuprolide side effect was reported by a Physician from JAPAN on Mar 14, 2006. Female patient, 51 years of age, was diagnosed with breast cancer
and was treated with Leuprolide. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased. Leuprolide dosage: unknown. Patient recovered.